Indication
Disseminated Histoplasma capsulatum infection
Disseminated *Histoplasma capsulatum* infection is a severe, life-threatening systemic fungal disease caused by the hematogenous spread of the dimorphic fungus *Histoplasma capsulatum* beyond the pulmonary system. Read more about Disseminated Histoplasma capsulatum infection
1 drugs 1 manufacturers
Drugs that treat it
Common Disseminated Histoplasma capsulatum infection therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDisseminated *Histoplasma capsulatum* infection is a severe, life-threatening systemic fungal disease caused by the hematogenous spread of the dimorphic fungus *Histoplasma capsulatum* beyond the pulmonary system.
It primarily affects individuals with impaired cell-mediated immunity—such as persons with HIV/AIDS, solid organ transplant recipients, or those receiving immunosuppressive therapies—as well as infants and older adults.
Pathophysiologically, inhaled microconidia convert into intracellular yeasts that evade phagolysosomal destruction within macrophages and disseminate through the reticuloendothelial system.
Defining clinical features include persistent fever, weight loss, hepatosplenomegaly, lymphadenopathy, pancytopenia from bone marrow infiltration, and potential multiorgan involvement including mucosal ulcers, adrenal insufficiency, or central nervous system lesions.
- nih.gov
Disseminated *Histoplasma capsulatum* infection is a severe, life-threatening systemic fungal disease caused by the hematogenous spread of the dimorphic fungus *Histoplasma capsulatum* beyond the pulmonary system It primarily affects individuals with impaired cell-mediated immunity—such as persons with HIV/AIDS, solid organ transplant recipients, or those receiving immunosuppressive therapies—as well as infants and older adults Pathophysiologically, inhaled microconidia convert into intracellula...
- hiv.gov
Disseminated *Histoplasma capsulatum* infection is a severe, life-threatening systemic fungal disease caused by the hematogenous spread of the dimorphic fungus *Histoplasma capsulatum* beyond the pulmonary system Defining clinical features include persistent fever, weight loss, hepatosplenomegaly, lymphadenopathy, pancytopenia from bone marrow infiltration, and potential multiorgan involvement including mucosal ulcers, adrenal insufficiency, or central nervous system lesions
- cdc.gov
It primarily affects individuals with impaired cell-mediated immunity—such as persons with HIV/AIDS, solid organ transplant recipients, or those receiving immunosuppressive therapies—as well as infants and older adults Pathophysiologically, inhaled microconidia convert into intracellular yeasts that evade phagolysosomal destruction within macrophages and disseminate through the reticuloendothelial system
- mayoclinic.org
Defining clinical features include persistent fever, weight loss, hepatosplenomegaly, lymphadenopathy, pancytopenia from bone marrow infiltration, and potential multiorgan involvement including mucosal ulcers, adrenal insufficiency, or central nervous system lesions
Personalize your experience
Follow Disseminated Histoplasma capsulatum infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.